Literature DB >> 2958849

Antigen-presenting B cells and helper T cells cooperatively mediate intravirionic antigenic competition between influenza A virus surface glycoproteins.

B E Johansson1, T M Moran, E D Kilbourne.   

Abstract

Parenteral vaccination of BALB/c mice primed by infection with H3N2 variants of influenza A virus results in a reduced production of N2 antibody in response to homologous (H3N2) vaccine compared with the response to an H7N2 vaccine equal in N2 immunologenicity. We now have studied the interaction in vitro of purified splenic B and T lymphocytes from variably immunized mice to ascertain the cellular basis of the hemagglutinin (HA)-influenced antibody response to neuraminidase (NA). Assay of the proliferative response of T cells in B/T-cell mixtures stimulated by H3N1 (HA-specific) and H6N2 (NA-specific) reassortant (recombinant) viruses in vitro has enabled us to differentiate cellular responses to HA and NA antigens. Using a factorial design in analysis of B/T-cell mixtures, we have shown that: (i) intravirionic HA is dominant over NA in both B- and T-cell priming; (ii) an increase in H3-specific B cells occurs in mice administered boosters of H3N2 vaccine, and an increase in N2-specific B cells occurs in those given a booster of H7N2 vaccine; and (iii) memory B cells function as antigen-presenting cells and interact with memory helper T cells in the mediation of intravirionic HA-NA antigenic competition in favor of HA. The damping of response to the NA antigen in favor of HA with reinfection prohibits balanced immunologic response to the two antigens. The present studies define further the complex immunology of influenza virus infection.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2958849      PMCID: PMC299186          DOI: 10.1073/pnas.84.19.6869

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  14 in total

1.  A serological recapitulation of human infection with different strains of influenza virus.

Authors:  T FRANCIS; F M DAVENPORT; A V HENNESSY
Journal:  Trans Assoc Am Physicians       Date:  1953

2.  Antigen-specific interaction between T and B cells.

Authors:  A Lanzavecchia
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

3.  Induction of partial immunity to influenza by a neuraminidase-specific vaccine.

Authors:  R B Couch; J A Kasel; J L Gerin; J L Schulman; E D Kilbourne
Journal:  J Infect Dis       Date:  1974-04       Impact factor: 5.226

4.  Antigenic competition and genetic control of the immune response. A hypothesis for intramolecular competition.

Authors:  M J Taussig; E Mozes; G M Shearer; M Sela
Journal:  Cell Immunol       Date:  1973-08       Impact factor: 4.868

5.  Studies on the mechanism of antigenic competition: analysis of competition between synthetic polypeptide antigens.

Authors:  M J Taussig; E Mozes; G M Shearer; M Sela
Journal:  Eur J Immunol       Date:  1972-10       Impact factor: 5.532

6.  Reactions of antibodies with surface antigens of influenza virus.

Authors:  R G Webster; W G Laver; E D Kilbourne
Journal:  J Gen Virol       Date:  1968-12       Impact factor: 3.891

7.  B cells as antigen-presenting cells: the requirement for B cell activation.

Authors:  T Kakiuchi; R W Chesnut; H M Grey
Journal:  J Immunol       Date:  1983-07       Impact factor: 5.422

8.  Antigen presentation by normal B cells, B cell tumors, and macrophages: functional and biochemical comparison.

Authors:  R W Chesnut; S M Colon; H M Grey
Journal:  J Immunol       Date:  1982-04       Impact factor: 5.422

9.  Influenza virus proteins. I. Analysis of polypeptides of the virion and identification of spike glycoproteins.

Authors:  R W Compans; H D Klenk; L A Caliguiri; P W Choppin
Journal:  Virology       Date:  1970-12       Impact factor: 3.616

10.  Comparative efficacy of neuraminidase-specific and conventional influenza virus vaccines in induction of antibody to neuraminidase in humans.

Authors:  E D Kilbourne
Journal:  J Infect Dis       Date:  1976-10       Impact factor: 5.226

View more
  54 in total

1.  Immune response to influenza vaccination in an elderly population.

Authors:  Lidia B Brydak; Magdalena Machała; Jolanta Myśliwska; Andrzej Myśliwski; Piotr Trzonkowski
Journal:  J Clin Immunol       Date:  2003-05       Impact factor: 8.317

2.  Cellular and humoral immune responses to rubella virus structural proteins E1, E2, and C.

Authors:  H H Chaye; C A Mauracher; A J Tingle; S Gillam
Journal:  J Clin Microbiol       Date:  1992-09       Impact factor: 5.948

3.  Inactivated seasonal influenza vaccines increase serum antibodies to the neuraminidase of pandemic influenza A(H1N1) 2009 virus in an age-dependent manner.

Authors:  Glendie Marcelin; Hilliary M Bland; Nicholas J Negovetich; Matthew R Sandbulte; Ali H Ellebedy; Ashley D Webb; Yolanda S Griffin; Jennifer L DeBeauchamp; Janet E McElhaney; Richard J Webby
Journal:  J Infect Dis       Date:  2010-10-27       Impact factor: 5.226

4.  Enhancement of SIV-specific cell mediated immune responses by co-administration of soluble PD-1 and Tim-3 as molecular adjuvants in mice.

Authors:  Lijun Xiao; Dimin Wang; Caijun Sun; Pingchao Li; Yi Jin; Liqiang Feng; Ling Chen
Journal:  Hum Vaccin Immunother       Date:  2013-12-10       Impact factor: 3.452

5.  Neuraminidase-specific antibody responses to inactivated influenza virus vaccine in young and elderly adults.

Authors:  D C Powers; E D Kilbourne; B E Johansson
Journal:  Clin Diagn Lab Immunol       Date:  1996-09

Review 6.  Advances in the development of influenza virus vaccines.

Authors:  Florian Krammer; Peter Palese
Journal:  Nat Rev Drug Discov       Date:  2015-03       Impact factor: 84.694

Review 7.  Contribution of antibody production against neuraminidase to the protection afforded by influenza vaccines.

Authors:  Glendie Marcelin; Matthew R Sandbulte; Richard J Webby
Journal:  Rev Med Virol       Date:  2012-03-22       Impact factor: 6.989

8.  Differential ability of B cells specific for external vs. internal influenza virus proteins to respond to help from influenza virus-specific T-cell clones in vivo.

Authors:  P A Scherle; W Gerhard
Journal:  Proc Natl Acad Sci U S A       Date:  1988-06       Impact factor: 11.205

9.  Extending the Stalk Enhances Immunogenicity of the Influenza Virus Neuraminidase.

Authors:  Felix Broecker; Allen Zheng; Nungruthai Suntronwong; Weina Sun; Mark J Bailey; Florian Krammer; Peter Palese
Journal:  J Virol       Date:  2019-08-28       Impact factor: 5.103

10.  Antibody response to influenza vaccination in splenectomized patients in Poland.

Authors:  Lidia B Brydak; Magdalena Machała; Paweł Łaguna; Roma Rokicka-Milewska
Journal:  J Clin Immunol       Date:  2004-05       Impact factor: 8.317

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.